CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

GlobeNewswire Clinical Studies
Original article

Final Phase 2a data reinforce the profile of BIOX-101, selected for a late-breaking oral presentation at the World Stroke Congress

Phase 2BIOX-101
Related Companies

Read the original article

Published by GlobeNewswire Clinical Studies on September 24, 2026 6:30 AM

Read Original